Latest News

Rai Way FY 2025 Earnings: Solid Margins and Steady TTM Progress Rai Way (BIT:RWAY) has put fresh numbers on the table for FY 2025, with Q3 revenue at €70.9 million and basic EPS of €0.087, backed by trailing twelve month revenue of €280.9 million and EPS of €0.335. The company has seen revenue move from €273.5 million in the twelve months to Q2 2024 to €280.9 million in the latest twelve month window, while TTM EPS has shifted from €0.331 to €0.335. This places margins and earnings quality...

Cardinal Infrastructure Group (CDNL) just closed FY 2025 with fourth quarter revenue of US$145.8 million and net income of US$2.9 million, translating to EPS of about US$0.20. Over the past year, the company has seen trailing 12 month revenue move from US$315.2 million to US$456.0 million, while trailing net margin sits at 5% compared with 6.8% a year earlier, setting a clear context for how profitability is tracking against growth. For investors, this mix of higher top line and softer...

Magna International (TSX:MG) has launched the DHD REX, a dedicated hybrid drive system for range extended electric vehicles. The DHD REX is designed as a ready to integrate, modular solution aimed at reducing cost and complexity for automakers. The new system broadens Magna's hybrid technology portfolio and targets demand for flexible electrification options. For investors watching TSX:MG, this move adds a new piece to Magna's role as an auto parts supplier in the global shift toward...

Latest FY 2025 Results: Revenue Pressure and Deep Losses at Sutro Biopharma (STRO) Sutro Biopharma (STRO) has put out fresh FY 2025 numbers, with Q3 total revenue of US$9.7 million, a basic EPS loss of US$6.70, and net income loss excluding extra items of US$56.9 million setting the tone for the update. The company has seen quarterly revenue move between US$8.5 million and US$63.7 million over the last six reported periods, while basic EPS has ranged from a loss of US$1.36 to a loss of...

Wondering if Reliance at around US$300.22 is offering value or asking you to pay up for quality is exactly the question this breakdown will help you tackle. The stock is up 0.4% over the last 7 days and 1.5% year to date, but a 5.9% pullback over the past month sits against a 4.1% 1 year return, 22.8% over 3 years and 115.4% over 5 years. Recent coverage has focused on Reliance as a long term Metals and Mining name. Investor attention has been drawn to how its multi year share performance...

HM International Holdings Limited ( HKG:8416 ) just released a solid earnings report, and the stock displayed some...

Meshek Energy - Renewable Energies (TASE:MSKE) reported third quarter FY 2025 revenue of ₪42.5 million, with basic EPS of ₪0.02 and net income, excluding extra items, of ₪13.6 million, as investors weigh these figures against a current share price of ₪10.8. The company reported revenue of ₪27.8 million in the second quarter of FY 2024, ₪37.2 million in the second quarter of FY 2025, and then ₪42.5 million in the latest quarter, while quarterly basic EPS moved from a loss of ₪0.03 to a loss of...

BioAge Labs (BIOA) just posted its FY 2025 third quarter numbers, reporting revenue of US$2.1 million and a basic EPS loss of US$0.56, alongside a net loss of US$20.2 million, keeping the story firmly in loss-making territory. Over recent quarters, revenue has moved from US$0 million in Q4 2024 to US$1.5 million in Q1 2025 and US$2.4 million in Q2 2025. Quarterly basic EPS has remained in loss-per-share territory between US$0.36 and US$0.60, which keeps the focus on the pace at which losses...

G. Willi-Food International (NasdaqCM:WILC) has just reported another solid stretch of results, with Q2 FY 2025 revenue of ₪160.5 million and basic EPS of ₪2.30, set against trailing twelve month EPS of ₪6.94 on revenue of ₪598.4 million as the company caps off a year where net earnings grew 132.9%. Over the past few reporting periods, revenue has moved from ₪146.7 million in Q2 FY 2024 to ₪160.5 million in Q2 FY 2025, while quarterly EPS has ranged from ₪0.49 to ₪2.30, feeding into a...

Sabaf (BIT:SAB) has laid out its FY 2025 picture with third quarter revenue of €69.3 million and net income of €2.1 million, set against a trailing 12 month net margin of 1.7% compared with 4.1% a year earlier. The company has seen trailing 12 month revenue move from €273.7 million in the second quarter of 2024 to €283.5 million in the third quarter of 2025, with net profit over that window easing from €12.9 million to €4.7 million as a €2.8 million non recurring loss feeds through the...

In recent quarters, Baupost steadily increased its stake in Eagle Materials Inc., with fourth-quarter 2025 filings showing a 27% rise in holdings since the prior quarter, while RBC Capital Markets initiated coverage with a Sector Perform rating. This combination of expanding institutional ownership and fresh analyst attention has brought new focus to how Eagle Materials’ mixed heavy and light building materials portfolio is being valued. Next, we’ll examine how Baupost’s larger position...

Many investors are considering whether Pop Mart International Group shares still represent good value after a strong run, or whether the price has already moved ahead of the fundamentals. The stock last closed at HK$217.2, with returns of 0.8% over 7 days, an 11.1% decline over 30 days, 12.5% year to date and 71.9% over 1 year, along with a very large 3-year return. Recent attention has focused on how Pop Mart fits into consumer trends in collectibles and branded merchandise, with investors...

Core & Main (CNM) has reported third quarter FY 2026 revenue of US$2.1 billion and basic EPS of US$0.72, with trailing twelve month revenue at US$7.8 billion and EPS at US$2.29. The company has seen revenue move from US$1.7 billion in Q4 FY 2025 to US$2.1 billion in Q3 FY 2026, while quarterly EPS has ranged from US$0.34 to US$0.72 over that span. This release is part of a steady earnings run supported by broadly consistent margins. See our full analysis for Core & Main. With the headline...

Even though Kingdee International Software Group Company Limited's ( HKG:268 ) recent earnings release was robust, the...

Why Hochschild Mining is on investors’ radar Hochschild Mining (LSE:HOC) has drawn attention after recent price moves, with the share price showing a 2.5% gain over the past day, compared with a weaker performance over the past week and month. See our latest analysis for Hochschild Mining. That 2.5% one day share price gain comes after a 22.5% 30 day share price decline. However, the 1 year and 3 year total shareholder returns are very large, suggesting long term momentum while short term...

Hyundai Wia Corporation's ( KRX:011210 ) stock was strong after they recently reported robust earnings. However, we...

SM Entertainment Co., Ltd. ( KOSDAQ:041510 ) announced strong profits, but the stock was stagnant. Our analysis...

Last week, you might have seen that China Hongqiao Group Limited ( HKG:1378 ) released its yearly result to the market...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Sanara MedTech (SMTI) just posted its latest FY 2025 numbers, with Q3 revenue at US$26.3 million and basic EPS of US$0.10 from continuing operations, while trailing twelve month figures show revenue of US$101.9 million and a basic EPS loss of US$0.71. Over recent quarters the company has seen revenue range from US$20.2 million to US$26.3 million and quarterly basic EPS swing between a loss of US$0.41 and a profit of US$0.10, with trailing twelve month earnings from discontinued operations...

Wondering whether ArcBest at around US$94.60 is offering value right now or asking too much of future expectations? This article breaks down what the current price could be telling you. The share price has moved 10.1% over the last 7 days, while the 30 day return stands at a 10.0% decline and the 1 year return is 29.7%, with 22.6% year to date. Recent news coverage has focused on ArcBest as a transportation and logistics player in a sector that often reacts quickly to shifts in freight...

Event context and recent share performance Exor (ENXTAM:EXO) has drawn investor attention after a period of weaker share performance, with the stock showing a 1-day return decline of 1.85% and a past month return decline of 13.31%. See our latest analysis for Exor. At the current share price of €63.5, the stock’s weaker short term share price returns, including a 30 day share price decline of 13.31% and a year to date share price decline of 12.95%, align with a 1 year total shareholder return...

Financial results set the stage for LENZ Therapeutics (LENZ) LENZ Therapeutics (LENZ) has reported fresh numbers for FY 2025, with third quarter revenue of US$12.5 million and a loss per share of US$0.59, as net income excluding extra items came in at a loss of US$16.7 million. The company’s revenue moved from US$0 in the second quarter of 2024 to US$12.5 million in the third quarter of 2025. Over the same period, basic EPS shifted from a loss of US$0.38 to a loss of US$0.59. This provides a...

If you are wondering whether Kanzhun's current share price reflects its real value, the recent moves in the stock give you plenty to think about. The stock closed at US$13.26, with returns of an 8.9% decline over the past week, a 24.1% decline over the past month, and a 36.6% decline year to date, adding to a 33.0% decline over the last year and a 28.9% decline over three years. These moves have put valuation firmly in focus for many investors who want to understand whether the share price...